Philips gets patent for open MRI
Philips has received a patent for a technology similar to that used in an open MRI scanner, but don't expect the company to introduce an open system based on the patent any time soon. The company confirmed that it has received the patent, but said that
Philips has received a patent for a technology similar to that used in an open MRI scanner, but don't expect the company to introduce an open system based on the patent any time soon. The company confirmed that it has received the patent, but said that it has no plans to develop a commercial product as described in the patent.
Philips is one of the few major MRI vendors that does not have an open-style magnet in its product line. The Dutch vendor has said that its short-bore magnets have advantages over open-style systems due to their higher field strengths and superconducting architectures.
The technology described in the patent, U.S. Patent No. 5,666,056, is for an MRI system with a main magnet that has a frame with two magnetic elements that face each other, creating a gap in which the patient is imaged.
A Philips spokesperson said the company doesn't plan to develop an open-style magnet based on the technology covered by the patent, but does not rule out the future development of a Philips open MRI scanner.
"We have no plans to develop the product as described (in the patent), which does resemble an open MR system," the spokesperson said. "However, as in any planning process, we are always evaluating product development to meet market demands."
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
